XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.4
SHARE-BASED COMPENSATION (Tables)
3 Months Ended
Jan. 29, 2023
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three-month periods ended January 29, 2023, and January 30, 2022.


    Three Months Ended  
   
January 29,
2023
   
January 30,
2022
 
Expense reported in:
           
Cost of goods sold
 
$
281
   
$
143
 
Selling, general, and administrative
   
1,378
     
1,180
 
Research and development
   
162
     
134
 
Total expense incurred
 
$
1,821
   
$
1,457
 
                 
Expense by award type:
               
Restricted stock awards
 
$
1,764
   
$
1,367
 
Stock options
   
1
     
38
 
Employee stock purchase plan
   
56
     
52
 
Total expense incurred
 
$
1,821
   
$
1,457
 
                 
Income tax benefits of share-based compensation
 
$
155
   
$
84
 
Share-based compensation cost capitalized
 
$
-
   
$
-
 
Restricted Stock Awards Activity The table below presents information on our restricted stock awards for the three-month periods ended January 29, 2023, and January 30, 2022.


   
Three Months Ended
 
   
January 29,
2023
   
January 30,
2022
 
Number of shares granted in period
   
786,500
     
535,400
 
Weighted-average grant-date fair value of awards (in dollars per share)
 
$
16.77
   
$
19.28
 
Compensation cost not yet recognized
 
$
18,526
   
$
15,106
 
Weighted-average amortization period for cost not yet recognized (in years)
   
3.2
     
3.0
 
Shares outstanding at balance sheet date
   
1,374,422
     
1,128,179
 
Stock Options Activity The table below presents information on our stock options for the three-month periods ended January 29, 2023, and January 30, 2022.


   
Three Months Ended
 
   
January 29,
2023
   
January 30,
2022
 
Number of options granted in period
   
-
     
-
 
Cash received from option exercised
 
$
563
   
$
3,714
 
Compensation cost not yet recognized
 
$
-
   
$
71
 
Weighted-average amortization period for cost not yet recognized (in years)
   
-
     
1.0
 
Information on Outstanding and Exercisable Option

Information on outstanding and exercisable option awards as of January 29, 2023, is presented below.

Options
 
Shares
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life (in years)
   
Aggregate
Intrinsic
Value
 
Outstanding and exercisable at January 29, 2023
   
528,551
   
$
10.11
   

3.28
   
$
4,605